On-Chip Biotechnologies Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
On-Chip Biotechnologies General Information
Description
Developer of a cell sorting device designed to provide damage-free and contamination-free cell sorting. The company's device mounts the liquid transfer system on a disposable exchange-type microchannel chip, eliminates the need for a sheath tank and a waste liquid tank, and separates cells by controlling the flow of the microchannel, enabling clients to minimize sorter-induced cellular stress by adopting a cell separation method that controls the flow of the microchannel.
Contact Information
Website
www.on-chip.co.jpCorporate Office
- 2-16-17 Nakamachi
- Koganei
- Tokyo, 184-0012
- Japan
Corporate Office
- 2-16-17 Nakamachi
- Koganei
- Tokyo, 184-0012
- Japan
On-Chip Biotechnologies Timeline
On-Chip Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Secondary Transaction - Private | 08-Aug-2025 | Completed | Profitable | |||
| 11. Later Stage VC (Series E3) | 07-May-2024 | Completed | Profitable | |||
| 10. Later Stage VC (Series E) | 01-Jun-2019 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 01-Jan-2018 | Completed | Generating Revenue | |||
| 8. Debt - General | 01-Jan-2016 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 01-Dec-2015 | Completed | Generating Revenue | |||
| 6. Debt - General | 01-Nov-2013 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 01-Oct-2013 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 01-Nov-2011 | $1.32M | $4.77M | Completed | Generating Revenue | |
| 3. Early Stage VC | 01-Dec-2009 | $1.05M | $3.46M | Completed | Startup |
On-Chip Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
On-Chip Biotechnologies Comparisons
Industry
Financing
Details
On-Chip Biotechnologies Competitors (1)
One of On-Chip Biotechnologies’s competitors is NanoCellect Biomedical, a Private Equity-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NanoCellect Biomedical | Private Equity-Backed | San Diego, CA |
On-Chip Biotechnologies Patents
On-Chip Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4484920-A1 | In-droplet particle detection method, method for fractioning/dispensing droplet including particles, method for removing particles to outside from droplet after dispensing, and device therefor | Pending | 25-Feb-2022 | ||
| EP-4484920-A4 | In-droplet particle detection method, method for fractioning/dispensing droplet including particles, method for removing particles to outside from droplet after dispensing, and device therefor | Pending | 25-Feb-2022 | ||
| US-20250172487-A1 | In-droplet particle detection method, method for fractioning/dispensing droplet including particles, method for removing particles to outside from droplet after dispensing, and device therefor | Pending | 25-Feb-2022 | ||
| WO-2023163162-A1 | In-droplet particle detection method, method for fractioning/dispensing droplet including particles, method for removing particles to outside from droplet after dispensing, and device therefor | Inactive | 25-Feb-2022 | ||
| EP-3960293-A2 | Method for purifying particles, method for dispensing a single particle, method for analyzing cell cluster, and apparatus using the same | Pending | 25-Aug-2020 | G01N15/1404 |
On-Chip Biotechnologies Signals
On-Chip Biotechnologies Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Relic | Accelerator/Incubator | Minority | ||
| TOHOKU University Venture Partners | Venture Capital | Minority | ||
| Daiwa Corporate Investment | Venture Capital | Minority |
On-Chip Biotechnologies Investments (1)
On-Chip Biotechnologies’s most recent deal was a Joint Venture with Joint Venture (OnChip Biotechnologies/Otsuka Electronics). The deal was made on 22-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (OnChip Biotechnologies/Otsuka Electronics) | 22-Nov-2023 | Joint Venture | Discovery Tools (Healthcare) |
On-Chip Biotechnologies FAQs
-
When was On-Chip Biotechnologies founded?
On-Chip Biotechnologies was founded in 2005.
-
Where is On-Chip Biotechnologies headquartered?
On-Chip Biotechnologies is headquartered in Tokyo, Japan.
-
What is the size of On-Chip Biotechnologies?
On-Chip Biotechnologies has 33 total employees.
-
What industry is On-Chip Biotechnologies in?
On-Chip Biotechnologies’s primary industry is Other Devices and Supplies.
-
Is On-Chip Biotechnologies a private or public company?
On-Chip Biotechnologies is a Private company.
-
What is On-Chip Biotechnologies’s current revenue?
The current revenue for On-Chip Biotechnologies is .
-
How much funding has On-Chip Biotechnologies raised over time?
On-Chip Biotechnologies has raised $18.9M.
-
Who are On-Chip Biotechnologies’s investors?
Relic, TOHOKU University Venture Partners, and Daiwa Corporate Investment have invested in On-Chip Biotechnologies.
-
Who are On-Chip Biotechnologies’s competitors?
NanoCellect Biomedical is a competitor of On-Chip Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process